Sharplink Inc. stocks have been trading up by 13.75 percent after upbeat coverage highlighted strong growth prospects and investor optimism.
Click Here for a Millionaire's POV on Trading SBET
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- Q2 2026 revenue jumped to $11.5M from $0.7M a year earlier, but SBET missed Street targets calling for $12.3M and near-breakeven EPS at $0.01.
- A huge GAAP net loss tied to non-cash Ethereum marks highlights how SBET’s ETH-heavy model amplifies earnings volatility even as it drives revenue growth.
- The company expanded to roughly 889,000 ETH, raised $75M at a premium to NAV, launched a $125M Galaxy onchain yield fund, bought back stock, and entered the Russell 2000/3000.
- Institutional ownership in SBET climbed to about 60%, the highest among ETH-focused treasury names, while a new Schedule 13G flagged another sizeable passive stake.
- TD Cowen, Canaccord, and B. Riley all cut SBET price targets but kept Buy ratings, with the stock still carrying an average Buy and a $16.61 mean target.
Live Update At 12:32:14 EDT: On Wednesday, August 19, 2026 Sharplink Inc. stock [NASDAQ: SBET] is trending up by 13.75%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
SBET has been grinding higher on the chart. Over the last few weeks, Sharplink Inc. has climbed from the low $6s to a recent close around $7.14, with the daily data showing a steady pattern of higher lows and higher closes. That’s exactly the kind of quiet trend many momentum traders hunt before a bigger move.
Intraday, SBET’s 5-minute tape shows an orderly push from the $6.40 area at the open toward the low $7s by midday, with shallow pullbacks and quick dips getting bought. That intraday stair-step action signals active day traders supporting the move rather than a one-and-done spike.
More Breaking News
- MRNA Stock Eyes Next Leg As FDA Clears New Flu Shot
- VRAX Stock Whipsaws As Traders Target Volatile Biotech Play
- Duolingo Stock Rebounds As Q2 Beat Fuels Bullish Targets
- Haemonetics Stock Climbs As Analysts Hike Price Targets
Fundamentally, Sharplink Inc. is a strange mix of strong growth and heavy red ink. Q2 revenue reached $11.5M, a massive jump from $0.7M a year ago, but it still fell short of the $12.3M analysts were looking for. The company posted a loss of $1.88 per share, narrower than last year’s $4.27 loss yet far from the near-breakeven EPS target. Key ratios show a business with very high gross margin, but deeply negative returns on equity and assets as GAAP results absorb Ethereum mark-to-market hits. For traders, SBET trades like a leveraged play on Ethereum wrapped in an operating company.
Why Traders Are Watching SBET Right Now
SBET is not your typical gaming or software ticker; it’s effectively an Ethereum treasury and yield machine with an operating wrapper. Q2 2026 numbers make that clear. Revenue surged, powered mainly by Sharplink Inc.’s actively managed ETH treasury and staking activities. At the same time, the company booked a very large GAAP net loss, primarily from non-cash unrealized losses and impairments on ETH and ETH-linked assets. In practice, that means the P&L can swing wildly with crypto marks even when cash operations are more stable.
The scale of SBET’s Ethereum bet is big. Sharplink Inc. expanded holdings to roughly 889,000 ETH and then turned that balance sheet into a weapon. The company raised $75M in a registered direct offering at a premium to NAV, repurchased shares, and helped launch the $125M Galaxy Sharplink Onchain Yield Fund, seeding it with $100M of staked ETH. For traders, that onchain yield fund is a major catalyst: SBET is trying to turn dormant treasury assets into a recurring yield business, which, if executed, can support higher revenue without linear cost growth.
Ownership trends give this story more teeth. Institutional ownership in SBET jumped roughly 12 points quarter-over-quarter to about 60%, now the highest among ETH-focused digital asset treasury players, and a Schedule 13G shows another large passive holder stepping in. That tells traders big money is lining up behind the Ethereum-centric strategy even as headline GAAP numbers look ugly.
On the Street, Sharplink Inc. remains a “reset but still bullish” name. TD Cowen cut its target from $16 to $13, citing a softer Ethereum outlook and weaker expected FY26 pricing. Canaccord slashed its target from $19 to $8 on a tougher backdrop and a more conservative 1x mNAV framework. B. Riley trimmed from $11 to $10. Yet all three kept Buy ratings, and SBET still carries an average Buy with a $16.61 mean target — a sizable implied upside from current levels.
Conclusion
For active traders, SBET sits at the crossroads of crypto volatility and small-cap momentum. The Q2 2026 picture is loud and messy: revenue rockets to $11.5M, losses improve but still miss, and the GAAP bottom line is crushed by non-cash Ethereum marks. At the same time, Sharplink Inc. leans fully into its ETH strategy, growing holdings, raising $75M at a premium to NAV, launching the Galaxy Sharplink Onchain Yield Fund, and even buying back shares.
The ownership and analyst backdrop tempers some of the risk. Institutional holders now control about 60% of SBET, plus a new Schedule 13G filer, signaling that the shareholder base is getting stronger and stickier. Analyst targets have been reset lower, but the consistent Buy ratings and $16.61 average target show that Wall Street still views Sharplink Inc. as a leveraged way to play Ethereum and onchain yield, not a broken story.
For traders, the lesson is classic. SBET’s chart is tightening, the story is polarizing, and volatility is the main edge. As Tim Sykes likes to hammer home, “trade the price action, not the hype — react, don’t predict.” That aligns with a growing focus on risk discipline in the day-trading world: as Tim Bohen, lead trainer with StocksToTrade says, “For me, trading is more about managing risk than finding the next big mover.”. With SBET tied so closely to Ethereum marks and sentiment, disciplined risk management, clear levels, and fast decision-making matter more than any long-term narrative. This article is for educational and research purposes only and should be used as one more data point in your own trading process.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

